Jensen Huang had previously estimated that practical quantum computing would be 15 to 30 years away, but he recently revised this timeline to 5 to 15 years.
Keep Reading →
March 24 - Hedge Funds, News
On Friday, Jim Cramer, host of Mad Money, addressed the current state of the stock market, giving a cautious recommendation to investors.
Keep Reading →
March 9 - Hedge Funds, News
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript February 28, 2025Recursion Pharmaceuticals, Inc. misses on earnings expectations.
Keep Reading →
March 3 - News, Transcripts
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
Keep Reading →
February 22 - Hedge Funds, Industries, News
Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.
Keep Reading →
February 19 - Hedge Funds, Industries, News
Investors are continuing to assess the impact of new LLMs in the AI industry. X.
Keep Reading →
February 19 - Hedge Funds, News
Nvidia has a reputation for identifying high-quality companies in their initial stages and betting on their success.
Keep Reading →
February 18 - News, Stock Analysis
Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with significant risks.
Keep Reading →
January 28 - Hedge Funds, News
Investments in the global healthcare industry have ramped up sharply since the COVID-19 pandemic.
Keep Reading →
January 23 - Hedge Funds, Industries, News, Tech
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
Keep Reading →
January 22 - Market Movers, News
In the third quarter of 2024, investment titan Blackrock released a commentary on the market outlook for artificial intelligence heading into the closing months of the year, stressing...
Keep Reading →
January 18 - Hedge Funds, Industries, News, Tech
"I want to discuss Bitcoin, really. I do—not to the detriment of stocks but in addition to stocks. I come to praise Bitcoin, not buy it.
Keep Reading →
December 11 - Hedge Funds, News
As artificial intelligence continues to reshape industries, experts are increasingly focusing on how its integration will impact investment strategies.
Keep Reading →
December 11 - Hedge Funds, News
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Keep Reading →
December 10 - News
Jim Cramer, the host of Mad Money, recently offered his views on several key topics, including Big Tech stocks and cryptocurrency.
Keep Reading →
December 4 - Hedge Funds, News
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
Keep Reading →
October 22 - Hedge Funds, News
Investing comes in all sizes and flavors.
Keep Reading →
September 8 - News
Generally, when you hear the term "artificial intelligence," your mind jumps straight to semiconductor and big tech companies that have been making huge profits as a result of...
Keep Reading →
August 26 - Hedge Funds, Industries, News
Chris Gibson: Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, delighted to be joining you on our L(earnings) today.
Keep Reading →
August 10 - News, Transcripts
Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giant's chips and technology for drug discovery.
Keep Reading →
May 30 - Hedge Funds, News
The AI-led stock rally that rewarded mega-cap technology stocks has finally started to trickle down to other industry players that were seemingly not related to the AI and tech...
Keep Reading →
May 30 - Hedge Funds, News
Chris Gibson: Hi, everybody.
Keep Reading →
May 10 - News, Transcripts
In this article, we will take a detailed look at the latest stocks Jim Cramer is recommending.
Keep Reading →
April 30 - Hedge Funds, News
Chris Gibson: Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I am really excited to welcome you to our first ever Learnings Call here at Recursion.
Keep Reading →
February 28 - News, Transcripts
This article presents an overview of Cathie Wood Was Buying These 5 Stocks for 2024. For a detailed overview of such stocks, read our article, Cathie Wood Was Buying These ...
Keep Reading →
February 28 - Hedge Funds, News
In this article, we look at 40 cities with the lowest life expectancy in the US.
Keep Reading →
January 11 - Lists, News
In this article, we look at 40 Cities With The Highest Life Expectancy In The US.
Keep Reading →
December 22 - Lists, News
In this piece, we will take a look at billionaire Druckenmiller's 5 stocks picks with huge upside potential. If you want to read our introduction to Mr.
Keep Reading →
December 8 - Hedge Funds, News
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Keep Reading →
September 29 - Hedge Funds, News
In this piece, we will take a look at billionaire Stanley Druckenmiller's top five small-cap stock picks.
Keep Reading →
August 19 - Hedge Funds, News
The biotech industry encompasses a wide range of fields, including genetic engineering, biomanufacturing, bioinformatics, and synthetic biology.
Keep Reading →
March 28 - Business, News
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian company that is operating in the domain of human antibodies.
Keep Reading →
January 10 - Hedge Funds, News
In this article, we discuss the top 10 picks of the Harvard University stock portfolio.
Keep Reading →
November 2 - Hedge Funds, News
Lux Capital, an investment management firm, published its second quarter 2022 investor letter – a copy of which can be downloaded here.
Keep Reading →
September 29 - Hedge Fund Investor Letters, News
In this article, we will look at Harvard University's latest stock portfolio and list its 5 best biotech stock picks.
Keep Reading →
September 15 - Hedge Funds, News
In the beginning of July, Cathie Wood of ARK Investment Management admitted that while her predictions about inflation were wrong, the US seems to be heading towards a deflationary...
Keep Reading →
July 28 - Hedge Funds, News
In this piece, we will take a look at the nine healthcare stocks to invest in today according to Stanley Druckenmiller.
Keep Reading →
April 21 - Hedge Funds, News
In this piece, we will take a look at the five biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management.
Keep Reading →
April 20 - Hedge Funds, News
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Keep Reading →
April 20 - Hedge Funds, News
In this article, we will look at 5 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
Keep Reading →
April 14 - Hedge Funds, News
In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Keep Reading →
February 17 - Hedge Funds, News
In this article, we discuss the 10 best biotech stocks under $20 in Cathie Wood's portfolio.
Keep Reading →
November 25 - Hedge Funds, News
In this article, we discuss the 5 new stock picks of billionaire Stanley Druckenmiller.
Keep Reading →
November 19 - Hedge Funds, News
In this article, we discuss the top 10 picks in Harvard University's stock portfolio.
Keep Reading →
October 11 - Hedge Funds, News
In this article, we discuss Cathie Wood stock portfolio: 10 newest stock picks this year.
Keep Reading →
October 8 - Hedge Funds, News
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Keep Reading →
September 29 - Hedge Funds, News
In this article, we discuss the 5 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
Keep Reading →
September 24 - Hedge Funds, News
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
Keep Reading →
September 14 - Hedge Fund Investor Letters, News